THR-18
- Generic Name
- THR-18
A Study of the Safety, Imaging and Clinical Outcomes of THR-18 in Acute Stroke Subjects Treated With tPA
Phase 2
- Conditions
- Ischemic Stroke
- Interventions
- First Posted Date
- 2015-10-08
- Last Posted Date
- 2015-11-17
- Lead Sponsor
- D-Pharm Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT02572336
- Locations
- 🇲🇩
Municipal Emergency Hospital, Chisinau, Moldova, Republic of
THR-18's Pharmacokinetics and Pharmacodynamics in Subjects With Acute Ischemic Stroke Treated With tPA
- First Posted Date
- 2013-10-08
- Last Posted Date
- 2015-02-04
- Lead Sponsor
- D-Pharm Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT01957774
- Locations
- 🇺🇦
State Medical Preventive Institution "Central Clinical Hospital of Ukrzaliznytsia", Kharkov, Ukraine
Study to Assess the Safety and Efficacy of THR-18 When Administered to Patients Suffering Acute Ischemic Stroke and Treated With Tissue Plasminogen Activator (tPA)
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- Thrombotech Ltd.
- Target Recruit Count
- 22
- Registration Number
- NCT01253512
- Locations
- 🇮🇱
Hadassah Medical Center,, Jerusalem, Israel
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath